Why the study?
Does rapid dantrolene administration with body temperature monitoring reduce mortality in Japanese patients with malignant hyperthermia events?
Does rapid dantrolene administration with body temperature monitoring reduce mortality in Japanese patients with malignant hyperthermia events?
Rapid administration of dantrolene and body temperature monitoring are associated with decreased mortality in malignant hyperthermia.
Answers are grounded in this paper and cite their sources.
May support rapid dantrolene and monitoring in MH events; leaves open need for prospective validation.
Dantrolene should be given as rapidly as possible once MH has been diagnosed. Beginning treatment at a more normal body temperature can prevent critical elevations associated with a worse prognosis.
No takes yet. Share an insight, caveat, or question.
Toyota et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: